Loading…
Cancer and blood concentrations of the comutagen harmane in essential tremor
Blood concentrations of harmane, a tremor‐producing neurotoxin, are elevated in essential tremor (ET). Harmane is also a comutagen. Using a case‐control design, we compared the prevalence of cancer in ET cases vs. controls, and determined whether blood harmane concentrations are elevated among ET ca...
Saved in:
Published in: | Movement disorders 2008-09, Vol.23 (12), p.1747-1751 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Blood concentrations of harmane, a tremor‐producing neurotoxin, are elevated in essential tremor (ET). Harmane is also a comutagen. Using a case‐control design, we compared the prevalence of cancer in ET cases vs. controls, and determined whether blood harmane concentrations are elevated among ET cases with cancer. 66/267 (24.7%) ET cases vs. 55/331 (16.6%) controls had cancer (adjusted OR 1.52, 95% CI 1.01–2.30, P = 0.04). Among specific cancer types, colon cancer was more prevalent in ET cases than controls (2.6% vs. 0.6%, P = 0.04). Log blood harmane concentration was higher in ET cases vs. controls (P = 0.02) and in participants with vs. without cancer (P = 0.02). Log blood harmane concentration was highest in ET cases with cancer when compared with other groups (P = 0.009). These links between cancer and ET and between high blood harmane and cancer in ET deserve further study. © 2008 Movement Disorder Society |
---|---|
ISSN: | 0885-3185 1531-8257 |
DOI: | 10.1002/mds.22084 |